logo
episode-header-image
Jan 2022
22m 55s

How The Actions Of Washington And Beijin...

FT Partner Studio
About this episode

In 1972, with Nixon’s visit to Beijing, the world watched as the political and economic landscape between China and the US changed dramatically. Four decades later, new political heads of state redefined the relationship once again, as Xi Jinping and Donald Trump took power – and aim at each other’s economies. This time, the world is watching ever more eagerly and apprehensively as the top two economic powerhouses vie for supremacy; whatever happens in the next five years will affect everyone in the world.


Here to help explain the relationship between the US and China is Andy Rothman, an Investment Strategist at Matthews Asia and an expert on China. He spent 14 years as CLSA’s China Macroeconomic Strategist and, prior to that, 17 years in the US Foreign Service, including his role as Head of the Macroeconomics and Domestic Policy Office of the US Embassy in Beijing. In total, Andy has lived and worked in China for more than 20 years. He now lives near San Francisco.


Our sources for the show: FT resources, US State Department, Richard Nixon Foundation, C-SPAN, Nikkei Asia, Reuters, The Washington Post. The Biden soundbites were taken from C-SPAN open content, and the Nixon soundbite was used with permission from The Richard Nixon Foundation.



This content is paid for by advertisers and is produced in partnership with the Financial Times' Commercial Department.



Hosted on Acast. See acast.com/privacy for more information.

Up next
Jun 13
Human Health: Society and the Future of Biotech
Biotechnology is the use of biology in the production of new products, services, and organisms with the aim of improving human health and society. In 2024, the global biotech market was worth $1.68 trillion. By application, the health segment was responsible for just over half of ... Show More
30m 35s
May 14
Money Movers: Solving The Cross-Border Payment Problem
Despite an interconnected and increasingly digitalised world, a historical black cloud has been hanging over an area of finance relied upon by institutions, retail and a billion people associated with migrant work: Cross-border payments.Domestic money transfer has seen a dramatic ... Show More
31m 53s
Apr 28
Mastering Change: The Future Looking CFO
In today’s competitive global landscape the responsibilities of CFOs are diversifying more than ever. The fast paced digital revolution, geopolitical uncertainty, economic volatility and the environmental impact of climate change means the modern CFO must adapt to future proof th ... Show More
30m 41s
Recommended Episodes
Jun 2023
101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”. If you want see how biotech can change the world of health, whilst potentially being capable of creating extraordi ... Show More
39m 55s
Feb 2024
Biotech Special: a16z and the Biotech Revolution with Vijay Pande
There is a revolution unfolding in biotech. The confluence of new biological methods like CRISPR, virtually unlimited computational capacity, and machine learning has fundamentally transformed our ability to engineer biology for wide-ranging applications. Andreessen Horowitz, or ... Show More
57m 1s
Jan 2024
Fireside Chat with Sean Duffy
Bio Eats World is now Raising Health!On this first episode of Raising Health, Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande, founding partner of Bio + Health.Sean and Vijay discuss the building and growth of Omada, from the early days to now. As the cofounder o ... Show More
32m 10s
Oct 2024
Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ... Show More
20m 43s
Jan 2025
Driving Disease Risk Prediction and Preventative Healthcare with AI - with Dan Elton of the National Human Genome Research Institute
Today’s guest is Dan Elton, Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to explore the transformative role of AI in healthcare. In his new role, Dan shares how his work at NIH focuses on integrati ... Show More
15m 14s
Feb 2025
Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research ... Show More
19m 3s
Feb 2025
Leading Stem Cell Expert: Stem Cells 101 - The Future of Medicine w/ Robert Hariri | EP #147
In this episode, Bob and Peter discuss Stem Cells 101, why it’s not available in America, and the importance of stem cell treatment for humanity.  Recorded on Nov 21st, 2024Views are my own thoughts; not Financial, Medical, or Legal Advice. Dr. Robert Hariri is the Chairman, Foun ... Show More
1h 18m
Feb 2024
Is CRISPR the New Sickle Cell Savior?
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind on ... Show More
24m 39s
Apr 2024
Switzerland, AI and Liquid Biopsies
AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only a ... Show More
36m 51s
Aug 2024
From Petri Dishes to Pitch Decks: Cultivating Health Care’s AI Future with Vijay Pande
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture capit ... Show More
54m 8s